Sign in to view content

A Multicenter Post-Authorization Safety Study of Patients Treated With Voretigene Neparvovec-rzyl Gene Therapy in the United States: Interim Analysis at 3 Years

Aaron Nagiel, MD, PhD

Video
Published 2024

Related

Episode 201: AMD Drug Updates with Dr. Allen Ho, including Gene Therapy
Jayanth Sridhar, MD
Member Podcasts
2019
Ixoberogene Soroparvovec (Ixo-vec) IVT Gene Therapy for Neovascular AMD: First Time 26-Week Interim Analysis Results from the Phase 2 LUNA Study
Charles C Wykoff, MD, PhD, FASRS
Updates from the Field
2024
Gene Therapy in Pediatric Retina Patients at the Bascom Palmer Eye Institute: What I Have Learned
Audina M. Berrocal, MD FASRS
Annual Meeting Talks
2019

Category: Hereditary Retinal Disease & Genetics

See more